Transradial Access Market Report – Research, Industry Analysis Reports and Market Demands

Transradial Access Market to 2027 - Global Analysis and Forecasts By Product (Catheters, Guidewire, Sheath and Sheath Introducer and Accessories); Application (Drug Administration, Diagnostics and Testing, Fluid and Nutrition Administration and Blood Transfusion); End User (Hospitals and Clinics, Ambulatory Surgical Centers and Others) and Geography

Request for Sample of this report

Buy now

Table of Content

1. Introduction

1.1 Scope Of The Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Global Transradial Access Market – By Product
- 1.3.2 Global Transradial Access Market – By Application
- 1.3.3 Global Transradial Access Market – By End User
- 1.3.4 Global Transradial Access Market – By Geography

2. Global Transradial Access Market – Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Global Transradial Access Market – Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 North America PEST Analysis
- 4.2.2 Europe PEST Analysis
- 4.2.3 Asia Pacific PEST Analysis
- 4.2.4 Middle East & Africa PEST Analysis
- 4.2.5 South & Central America PEST Analysis

5. Global Transradial Access Market – Key Industry Dynamics

5.1 Key Market Drivers
- 5.1.1 Rising Inclination For Interventional Procedures Using Radial Artery Access
- 5.1.2 Increasing Prevalence Of Obesity & Lifestyle Diseases
- 5.1.3 Growing Use Of Radial Access Devices In Pediatric Patients
5.2 Key Market Restraints
- 5.2.1 Product Recalls & Failures
- 5.2.2 High Costs Of Vascular Access Devices
5.3 Key Market Opportunities
- 5.3.1 Technological Developments
- 5.3.2 High Market Potential In Emerging Nations
5.4 Current Trend
- 5.4.1 Use Of Miniature Transradial Access Devices
5.5 Impact Analysis

6. Transradial Access Market – Global Analysis

6.1 Global Transradial Access Market Revenue Forecasts And Analysis
6.2 Global Transradial Access Market, By Geography - Forecasts And Analysis
6.3 Positioning Of Key Players

7. Global Transradial Access Market Analysis– By Product

7.1 Overview
7.2 Global Transradial Access Market By Product, 2018 & 2027 (%)
7.3 Catheter Market
- 7.3.1 Overview
- 7.3.2 Global Catheter Market Revenue And Forecasts To 2027 (US$ Mn)
7.4 Guidewire Market
- 7.4.1 Overview
- 7.4.2 Global Guidewire Market Revenue And Forecasts To 2027 (US$ Mn)
7.5 Sheaths & Sheath Introducers Market
- 7.5.1 Overview
- 7.5.2 Global Sheaths & Sheath Introducers Market Revenue And Forecasts To 2027 (US$ Mn)
7.6 Accessories Market
- 7.6.1 Overview
- 7.6.2 Global Accessories Market Revenue And Forecasts To 2027 (US$ Mn)

8. Global Transradial Access Market Analysis– By Application

8.1 Overview
8.2 Global Transradial Access Market By Application, 2018 & 2027 (%)
8.3 Drug Administration Market
- 8.3.1 Overview
- 8.3.2 Global Drug Administration Market Revenue And Forecasts To 2027 (US$ Mn)
8.4 Fluid And Nutrition Administration Market
- 8.4.1 Overview
- 8.4.2 Global Fluid And Nutrition Administration Market Revenue And Forecasts To 2027 (US$ Mn)
8.5 Blood Transfusion Market
- 8.5.1 Overview
- 8.5.2 Global Blood Transfusion Market Revenue And Forecasts To 2027 (US$ Mn)
8.6 Diagnosis & Testing Market
- 8.6.1 Overview
- 8.6.2 Global Diagnosis & Testing Market Revenue And Forecasts To 2027 (US$ Mn)

9. Global Transradial Access Market Analysis– By End User

9.1 Overview
9.2 Global Transradial Access Market, By End User 2018 & 2027 (%)
9.3 Hospitals & Clinics Market
- 9.3.1 Overview
- 9.3.2 Global Hospitals & Clinics Market Revenue And Forecasts To 2027 (US$ Mn)
9.4 Ambulatory Surgical Centers Market
- 9.4.1 Overview
- 9.4.2 Global Ambulatory Surgical Centers Market Revenue And Forecasts To 2025 (US$ Mn)
9.5 Others Market
- 9.5.1 Overview
- 9.5.2 Global Others Market Revenue And Forecasts To 2025 (US$ Mn)

10. Transradial Access Market Revenue And Forecasts To 2027 – Geographical Analysis

Description

The global transradial access market is expected to reach US$ 2,961.79 Mn in 2027 from US$ 1,574.97 Mn in 2018. The market is estimated to grow with a CAGR of 7.7% from 2019-2027.
The market for transradial access is expected to grow, owing to factors such as rising inclination for interventional procedures using radial artery access, increasing prevalence of obesity & lifestyle diseases and growing use of radial access devices in pediatric patients. However, the factors such as product recalls & failures and high costs of vascular access devices are likely to adversely impact the growth of the market in the forecast period.
Transradial catheterization is an endovascular procedure or catheterization procedure done for the diagnosis and treatment of arterial disease. Transradial artery access for percutaneous coronary intervention is related to lower bleeding and vascular complications than transfemoral artery access, particularly in patients with acute coronary syndromes.
While the performance and functionality of the access devices are key factors for health, they are of critical importance for access devices classified as medical devices. These products risk a recall by the U.S. Food and Drug Administration (FDA) and/or Health Canada if they provide inaccurate analyses. Some transradial access devices currently on the market have produced noticeably incorrect data, leading consumers to question the utility. The number of product recalls are becoming a matter of concern for the manufacturers. Hence, the product recalls & failures are expected to hinder the growth of the market in the future years.
Global transradial access market is segmented by product, application and end user. On the basis of product, the market is segmented into catheters, guidewire, sheaths & sheath introducers and accessories. On the basis of application, the market is segmented into drug administration, diagnostics & testing, fluid and nutrition administration, blood transfusion. On the basis of end user, the market is segmented into hospitals & clinics, ambulatory surgical centers and others. In 2018, the hospitals & clinics segment held the largest share in the market.
Some of the major primary and secondary sources included in the report are, Food and Drug Administration, World Health Organization, Health Canada, International Diabetes Federation (IDF), American Hospital Association (AHA), National Cancer Institute (NCI), and others.